<DOC>
	<DOCNO>NCT00002297</DOCNO>
	<brief_summary>The objective study determine effect isoprinosine patient diagnose unexplained generalize lymphadenopathy . Variables examine include : Signs symptom : - Lymphadenopathy . - Fever . - Weight loss . - Occurrence opportunistic infection . Cell-mediated immune system parameter : - T-helper cell ( OKT4 ) number proportion . - T-suppressor cell ( OKT8 ) number proportion . - Natural killer ( NK ) cell activity . - Lymphocyte blastogenic response phytohemagglutinin ( PHA ) . - Lymphocyte blastogenic response pokeweed mitogen ( PWM ) . - Immunoglobulin ( IgG , IgA , IgM , IgE , IgD ) profile . - Circulating immune complex . Infections characteristically associate AIDS , Candida albicans , Pneumocystis carinii pneumonia , Cytomegalovirus , Herpes simplex , Cryptococcus , Histoplasma , Toxoplasma , Cryptosporidium , Mycobacterium avium- intracellulare , Legionella , Isospora . Safety parameter : - Blood chemistry include serum uric acid ( PurposeA-12 ) . - Complete blood count ( CBC ) . - Platelet count .</brief_summary>
	<brief_title>A Study Isoprinosine Patients With Lymph Node Disease</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lymphatic Diseases</mesh_term>
	<mesh_term>Inosine Pranobex</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition : Patients history gout , uric acid urolithiasis , uric acid nephrolithiasis , renal dysfunction , gastric ulceration exclude . Concurrent Medication : Excluded : Systemic corticosteroid . Cytotoxic immunosuppressive agent . Radiotherapy . Critically ill patient CDCdefined AIDS exclude . Prior Medication : Excluded within 1 month study entry : Immunotherapy . Patients persistent generalize lymphadenopathy ( PGL ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1989</verification_date>
	<keyword>Inosine Pranobex</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>